BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹241 Cr | ₹336 Cr | ₹279 Cr | ₹231 Cr | ₹46 Cr |
What is the latest Revenue of BALAXI PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹336 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹231 Cr |
| Mar2021 | ₹46 Cr |
How is Revenue of BALAXI PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -28.28 | |
| Mar2024 | ₹336 Cr | 20.42 | |
| Mar2023 | ₹279 Cr | 20.77 | |
| Mar2022 | ₹231 Cr | 406.94 | |
| Mar2021 | ₹46 Cr | - | |
Compare Revenue of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹149.4 Cr | -0.4% | -20.4% | -62.6% | Stock Analytics | |
| ADANI ENTERPRISES | ₹294,796.0 Cr | 1.2% | 0.8% | -10.9% | Stock Analytics | |
| REDINGTON | ₹21,600.4 Cr | 1.4% | -1.9% | 44.2% | Stock Analytics | |
| MMTC | ₹10,095.0 Cr | 2.4% | 10.8% | -6.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,568.4 Cr | 0.2% | 12.3% | 37.2% | Stock Analytics | |
| HONASA CONSUMER | ₹9,523.6 Cr | 5.6% | -0.7% | 14.4% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -0.4% |
-20.4% |
-62.6% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses